Azzad Asset Management Inc. ADV Cuts Position in Agilent Technologies, Inc. (NYSE:A)

Azzad Asset Management Inc. ADV cut its stake in Agilent Technologies, Inc. (NYSE:A) by 46.6% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,592 shares of the medical research company’s stock after selling 11,847 shares during the period. Azzad Asset Management Inc. ADV’s holdings in Agilent Technologies were worth $1,978,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Livelsberger Financial Advisory bought a new stake in Agilent Technologies in the fourth quarter worth $26,000. MV Capital Management Inc. lifted its stake in Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after purchasing an additional 105 shares during the last quarter. VisionPoint Advisory Group LLC bought a new stake in Agilent Technologies in the fourth quarter worth $29,000. Rise Advisors LLC lifted its stake in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the last quarter. Finally, Baystate Wealth Management LLC lifted its stake in Agilent Technologies by 107.3% in the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after purchasing an additional 133 shares during the last quarter.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the sale, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the sale, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

A stock opened at $126.13 on Thursday. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The company has a market cap of $36.80 billion, a P/E ratio of 29.82, a PEG ratio of 4.40 and a beta of 1.05. The firm has a 50-day moving average of $139.17 and a 200 day moving average of $138.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The business had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business’s revenue was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.27 earnings per share. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Analyst Ratings Changes

Several analysts have weighed in on A shares. Robert W. Baird lowered their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research note on Thursday, May 30th. JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Wolfe Research downgraded shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Stifel Nicolaus lowered their price objective on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. Finally, TD Cowen lowered their price objective on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. One analyst has rated the stock with a sell rating, seven have given a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Hold” and a consensus target price of $137.13.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.